Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to $23.3 million.

  • Integra Lifesciences Holdings' Change in Inventory rose 12662.85% to $23.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.0 million, marking a year-over-year decrease of 2.95%. This contributed to the annual value of $28.1 million for FY2024, which is 5290.68% down from last year.
  • According to the latest figures from Q3 2025, Integra Lifesciences Holdings' Change in Inventory is $23.3 million, which was up 12662.85% from $6.4 million recorded in Q2 2025.
  • In the past 5 years, Integra Lifesciences Holdings' Change in Inventory ranged from a high of $25.4 million in Q1 2023 and a low of -$9.0 million during Q4 2021
  • Moreover, its 5-year median value for Change in Inventory was $6.5 million (2021), whereas its average is $8.2 million.
  • Over the last 5 years, Integra Lifesciences Holdings' Change in Inventory had its largest YoY gain of 52986.75% in 2021, and its largest YoY loss of 41849.49% in 2021.
  • Integra Lifesciences Holdings' Change in Inventory (Quarter) stood at -$9.0 million in 2021, then surged by 152.17% to $4.7 million in 2022, then skyrocketed by 250.84% to $16.4 million in 2023, then tumbled by 96.53% to $570000.0 in 2024, then surged by 3995.61% to $23.3 million in 2025.
  • Its last three reported values are $23.3 million in Q3 2025, $6.4 million for Q2 2025, and $13.7 million during Q1 2025.